Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Flechas, Ivonne D ^a   Cuellar, Adriana ^a   Cucunubá, Zulma M ^b   Rosas, Fernando ^c   Velasco, Víctor ^c   Steindel, Mario ^d   Thomas, María D C ^e   López, Manuel C ^e   González, John M ^f   Puerta, Concepción J ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b INSTITUTO NACIONAL DE SALUD   (Colombia)

^c Fundacion Clinica Shaio   (Colombia)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^e INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^f UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; KINETOPLASTID MEMBRANE PROTEIN II ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREVALENCE; TRYPANOSOMA; TRYPANOSOMA CRUZI; ANTIBODY SPECIFICITY; BLOOD; CASE CONTROL STUDY; COLOMBIA; IMMUNOLOGY;

ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; BRAZIL; CASE-CONTROL STUDIES; CHAGAS DISEASE; COLOMBIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TRYPANOSOMA;

EID: 71949119401     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-186     Document Type: Article

References (43)

1. Goto Y, Carter D, Reed SG. Immunological dominance of Trypanosoma cruzi tandem repeat proteins. Infect Immun 2008, 76:3967-3974. 10.1128/IAI.00604-08, 2519453, 18625739.
2. Campo VA, Buscaglia CA, Di Noia JM, Frasch AC. Immunocharacterization of the mucin-type proteins from the intracellular stage of Trypanosoma cruzi. Microbes Infect 2006, 8:401-409. 10.1016/j.micinf.2005.07.008, 16253534.
3. Cooley G, Etheridge RD, Boehlke C, Bundy B, Weatherly DB, Minning T, Haney M, Postan M, Laucella S, Tarleton RL. High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Negl Trop Dis 2008, 2:e316. 10.1371/journal.pntd.0000316, 2556098, 18841200.
4. Bhatia V, Garg NJ. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice. Clin Vaccine Immunol 2008, 15:1158-1164. 10.1128/CVI.00144-08, 2519298, 18550728.
5. Rodriguez AM, Santoro F, Afchain D, Bazin H, Capron A. Trypanosoma cruzi infection in B-cell-deficient rats. Infect Immun 1981, 31:524-529. 351339, 6783543.
6. Scott MT. The nature of immunity against Trypanosoma cruzi in mice recovered from acute infection. Parasite Immunol 1981, 3:209-218. 10.1111/j.1365-3024.1981.tb00400.x, 6795575.
7. World Health Organization Control of Chagas' disease. WHO Technical Report Series 2002, 905:1-120.
8. Dutra WO, Rocha MO, Teixeira MM. The clinical immunology of human Chagas disease. Trends Parasitol 2005, 21:581-587. 10.1016/j.pt.2005.09.007, 16236550.
9. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123. 10.1161/CIRCULATIONAHA.106.624296, 17339569.
10. Tarleton RL. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 2007, 19:430-434. 10.1016/j.coi.2007.06.003, 17651955.
11. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol 2005, 21:513-516. 10.1016/j.pt.2005.08.013, 16125464.
12. Umekita L, Ramos D, Barbaro K, Mota I. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes. Immunol Lett 1999, 10:73-76.
13. Umekita LF, Mota I. How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?. Braz J Med Biol Res 2000, 33:253-258. 10.1590/S0100-879X2000000300001, 10719375.
14. Stebeck CE, Beecroft RP, Singh BN, Jardim A, Olafson RW, Tuckey C, Prenevost KD, Pearson TW. Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol 1995, 71:1-13. 10.1016/0166-6851(95)00022-S, 7630374.
15. Thomas MC, García-Pérez JL, Alonso C, López MC. Molecular characterization of KMP11 from Trypanosoma cruzi: a cytoskeleton-associated protein regulated at the translational level. DNA Cell Biol 2000, 19:47-57. 10.1089/104454900314708, 10668791.
16. Olson CL, Nadeau KC, Sullivan MA, Winquist AG, Donelson JE, Walsh CT, Engman DM. Molecular and biochemical comparison of the 70-kDa heat shock proteins of Trypanosoma cruzi. J Biol Chem 1994, 269:3868-3874.
17. Requena JM, López MC, Jimenez-Ruiz A, de la Torre JC, Alonso C. A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res 1988, 16:1393-1406. 10.1093/nar/16.4.1393, 336323, 2831499.
18. Requena JM, Jimenez-Ruiz A, Soto M, Assiego R, Santarén JF, Lopez MC, Patarroyo ME, Alonso C. Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol 1992, 53:201-211. 10.1016/0166-6851(92)90022-C, 1501640.
19. Sambrook JF, Russell DW. Molecular Cloning, A Laboratory Manual 2001, New York: Cold Spring Harbor Laboratory, 3.
20. Thomas MC, Longobardo MV, Carmelo E, Maranon C, Planelles L, Patarroyo ME, Alonso C, Lopez MC. Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol 2001, 123:465-471. 10.1046/j.1365-2249.2001.01478.x, 1906009, 11298135.
21. Planelles L, Thomas M, Pulgar M, Marañón C, Grabbe S, López MC. Trypanosoma cruzi heat-shock protein-70 kDa, alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells. Immunol Cell Biol 2002, 80:241-247. 10.1046/j.1440-1711.2002.01081.x, 12067411.
22. Cuellar A, Santander SP, Thomas MC, Guzmán F, Gómez A, López MC, Puerta CJ. Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol Cell Biol 2008, 86:255-260. 10.1038/sj.icb.7100146, 18180802.
23. Steindel M, Pacheco LK, Scholl D, Soares M, de Moraes MH, Kosmann C, Sincero TC, Stoco PH, Murta SMF, Carvalho-Pinto CJ, Grisard EC. Characterization of Trypanosoma cruzi isolated from humans and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina, Brazil. Diagn Microbiol Infect Dis 2008, 60:25-32.
24. Beltrán M, Duque S, Guhl F, Herrera CP, López MC, Moreno AL, Nicholls RS, Santacruz MM. Prueba de ELISA y prueba de inmunofluorescencia indirecta (IFI). Manual de procedimientos para el diagnóstico de la enfermedad de Chagas 2001, 32-48. Bogotá:Ministerio de Salud, Guhl F, Nicholls RS.
25. Milei J, Guerri-Guttenberg RA, Grana DR, Storino R. Prognostic impact of Chagas disease in the United States. Am Heart J 2009, 157:22-29. 10.1016/j.ahj.2008.08.024, 19081392.
26. Llewellyn MS, Miles MA, Carrasco HJ, Lewis MD, Yeo M, Vargas J, Torrico F, Diosque P, Valente V, Valente SA, Gaunt MW. Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLoS Pathog 2009, 5:e1000410. 10.1371/journal.ppat.1000410, 2669174, 19412340.
27. Krettli AU, Brener Z. Protective effects of specific antibodies in Trypanosoma cruzi infections. J Immunol 1976, 116:755-760.
28. Franchin G, Pereira-Chioccola VL, Schenkman S, Rodrigues MM. Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice. Infect Immun 1997, 65:2548-2554. 175360, 9199418.
29. Díez H, Guzmán F, Alba MP, Cuéllar A, Thomas MC, López MC, Rosas F, Velasco V, González JM, Patarroyo ME, Puerta CJ. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein. Peptides 2007, 28:1520-1526. 10.1016/j.peptides.2007.06.017, 17683828.
30. Umezawa ES, Nascimento MS, Kesper N, Coura JR, Borges-Pereira J, Junqueira AC, Camargo ME. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J Clin Microbiol 1996, 34:2143-2147. 229206, 8862574.
31. Takehara HA, Da Silva AM, Brodskyn CI, Mota I. A comparative study of anti-Trypanosoma cruzi serum obtained in acute and chronic phase of infection in mice. Immunol Lett 1989, 23:81-85. 10.1016/0165-2478(89)90117-X, 2517266.
32. Mejía-Jaramillo AM, Peña VH, Triana-Chávez O. Trypanosma cruzi: biological characterization of lineages I and II supports the predominance of lineage I en Colombia. Exp Parasitol 2009, 121:83-91. 10.1016/j.exppara.2008.10.002, 18950627.
33. dos Santos DM, Talvani A, Guedes PM, Machado-Coelho GL, de Lana M, Bahia MT. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. Exp Parasitol 2009, 121:8-14. 10.1016/j.exppara.2008.09.012, 18848935.
34. Requena JM, Soto M, Guzman F, Maekelt A, Noya O, Patarroyo ME, Alonso C. Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol Immunol 1993, 30:1115-1121. 10.1016/0161-5890(93)90158-8, 8366861.
35. Rico AL, Gironès N, Fresno M, Alonso C, Requena JM. The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones 2002, 7:339-346. 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2, 514833, 12653478.
36. de Moraes MH, Guarneri AA, Girardi FP, Rodrigues JB, Eger I, Tyler KM, Steindel M, Grisard EC. Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera. Parasit Vectors 2008, 1:20. 10.1186/1756-3305-1-20, 2475519, 18611261.
37. Cerban FM, Gea S, Menso E, Vottero-Cima E. Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clin Immunol Immunopatho 1993, 67:25-30.
38. Morgan J, Pinto JC, Dias E, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 1996, 55:355-359.
39. Hernández-Becerril N, Nava A, Reyes PA, Monteón VM. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex. 2001, 71:199-205.
40. Trujillo C, Ramírez R, Vélez ID, Berberich C. The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas diseaseChagas' disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Lett 1999, 70:203-209. 10.1016/S0165-2478(99)00146-7, 10656675.
41. Solana ME, Katzin AM, Umezawa ES, Miatello CS. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease. J Clin Microbiol 1995, 33:1456-1460. 228195, 7650167.
42. Verçosa AF, Lorena VM, Carvalho CL, Melo MF, Cavalcanti MG, Silva ED, Ferreira AG, Pereira VR, Souza WV, Gomes YM. Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients. J Clin Lab Anal 2007, 21:271-276. 10.1002/jcla.20186, 17847109.
43. Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 1974, 19:259-294. full_text, 4611173.